1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Essential Thrombocythaemia: new trials by email Literature Review of Essential Thrombocythaemia trials Research Report on Essential Thrombocythaemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial STP938 - Essential Thrombocythaemia | Phase 2 | Recruiting | Step Pharma, SAS | 50 | 2025-06-18 | 2026-06-16 |
| The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET) anagrelide hydrochloride - Essential Thrombocythaemia | Phase 2 | Completed | Shire | 24 | 2006-11-13 | 2021-06-29 |
Thrombocythemia, Essential (2)
Blood Coagulation Disorders (2) · Blood Platelet Disorders (2) · Bone Marrow Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Myeloproliferative Disorders (2) · Thrombocytosis (2)
anagrelide (1)
Shire (1) · Step Pharma, SAS (1)
United Kingdom (2) · France (1) · Spain (1) · Sweden (1)
Maureen Higgins (1)
2004 (1)